相关实验视频

Updated: Jun 12, 2025

Modulating Cognition Using Transcranial Direct Current Stimulation of the Cerebellum

Modulating Cognition Using Transcranial Direct Current Stimulation of the Cerebellum

Published on: February 15, 2015

非侵入性脑刺激对抑郁症认知障碍的影响:系统性审查和元分析

Xin Xia¹, Chuan Huang¹, Zhixin Chen¹

¹Chengdu University of Traditional Chinese Medicine, Chengdu, China.

Asian journal of psychiatry

|June 10, 2025

概括

非侵入性脑刺激 (NIBS) 在抑郁症患者中显著改善了全球认知功能和学习/记忆. 然而,对其他认知领域的影响需要进一步研究.

科学领域:

神经科学是一个神经科学.
精神病学是一个精神病学.
认知科学认知科学

背景情况:

认知缺陷在抑郁症中很常见.
非侵入性脑刺激 (NIBS) 已被确立为抑郁症治疗.
对抑郁症认知缺陷的NIBS疗效需要进一步阐明.

研究的目的:

通过元分析系统地评估NIBS在改善抑郁症患者认知缺陷方面的有效性.

主要方法:

在主要数据库中进行了全面的文献搜索,截至2025年2月20日.
包括23个随机对照试验,共有1267名参与者.
评估对全球认知,学习/记忆,工作记忆,语言,精神运动速度,注意力,视觉空间能力和执行功能的影响.

主要成果:

NIBS显著改善了全球认知功能 (SMD=0.24),学习和记忆 (SMD=0.46).
与安慰剂相比,跨磁刺激 (TMS) 对全球认知功能显著改善 (SMD=0.32).
在其他认知领域没有观察到显著的改善.

结论:

在患有抑郁症的患者中,NIBS在改善全球认知功能和学习/记忆方面表现出显著的有效性.
目前的证据不支持该人群中其他认知领域的NIBS疗效.
需要进一步进行高质量的研究,以确定针对特定认知功能的最佳NIBS协议.

关键词:

认知功能障碍认知功能障碍抑郁症抑郁症抑郁症非侵入性大脑刺激通过骨进行直流刺激.通过骨磁刺激进行磁性刺激.

更多相关视频

Transcranial Direct Current Stimulation and Simultaneous Functional Magnetic Resonance Imaging

Transcranial Direct Current Stimulation and Simultaneous Functional Magnetic Resonance Imaging

Published on: April 27, 2014

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

相关概念视频

Brain Imaging

Brain Imaging

Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.